Omicron surges in Europe as Italy and Spain tighten restrictions – BBC News
Italy and Spain are the latest European countries to tighten coronavirus restrictions in an effort to curb the spread of the Omicron … source
Sarepta surges after Pfizer gene therapy data raises safety concerns
(Reuters) – Shares of Sarepta Therapeutics Inc (SRPT.O) surged 15% on Friday after some safety concerns were raised in a small, early-stage study of a competing gene therapy for a…
Pfizer makes $10.6 billion cancer bet in cash deal for Array Biopharma
(Reuters) – Pfizer Inc on Monday said it would buy Array Biopharma Inc for $10.64 billion in cash, a deal it hopes will help make it a leader in colon…
Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study
(Reuters) – A lower dose of non-opioid painkiller developed by Pfizer Inc and Eli Lilly and Co failed to meet main goals in a late-stage study in patients with moderate-to-severe…
Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study
(Reuters) – A lower dose of non-opioid painkiller developed by Pfizer Inc and Eli Lilly and Co failed to meet main goals in a late-stage study in patients with moderate-to-severe…
FDA approves Pfizer’s biosimilar to Roche’s Herceptin
FILE PHOTO: The logo of U.S. pharmaceutical corporation Pfizer Inc. is seen at a branch in Zurich, Switzerland October 2, 2018. REUTERS/Arnd Wiegmann (Reuters) – The U.S. Food and Drug…
Pfizer bets on biotech flu vaccine in $425 million BioNTech alliance
FRANKFURT (Reuters) – Pfizer has agreed to pay German biotech firm BioNTech up to $425 million in an alliance to develop more effective influenza jabs, the latest among several major…
Pfizer-Lilly pain drug meets late-stage trial goals
(Reuters) – An experimental osteoarthritis drug developed by Pfizer Inc and Eli Lilly and Co achieved its main goal of lowering pain in a late stage trial, the companies said…
Australian anti-trust watchdog loses appeal against Pfizer over Lipitor sales
MELBOURNE (Reuters) – An Australian court dismissed an appeal by the nation’s anti-trust watchdog in a case against Pfizer Inc in which the regulator alleged the company had used its…
Pfizer to pay $23.85 million to resolve U.S. kickbacks case
(Reuters) – Pfizer Inc (PFE.N) has agreed to pay $23.85 million to resolve allegations it illegally paid kickbacks to Medicare patients through a purportedly independent charitable foundation, the U.S. Department…